[Quality of life in patients with lower urinary tract symptoms after TURP for benign prostatic hyperplasia]

To date, the gold standard for the surgical management of BPH is transurethral resection of the prostate (TURP). Most patients who undergo TURP for BPH experience immediate effects and complete relief of lower urinary tract symptoms and do not need further urological care. However, some patients after this operation have some level of persistent residual lower urinary tract symptoms, which may require additional therapy.

To investigate voiding function and the need for medical therapy in patients who underwent TURP for LUTS due to BPH.

This study was performed as an anonymous survey among male patients presenting to a urology clinic. During the visit, the patients were offered to fill out I-PSS and SF-36 questionnaires. Also, they were asked about their socio-economic status, history of BPH, their perception of surgery and the postoperative period up to the day of the interview, presence or absence of symptoms of voiding dysfunction and any drug therapy at the time of the interview or after surgery. The patients also rated the severity of the symptoms using the IPSS questionnaire. The study comprised patients after 12 months to 3 years following successful TURP for LUTS due to BPH. A total of 1100 questionnaires were forwarded to researchers for interviewing patients who underwent TURP for prostatic hyperplasia.

After collecting and reviewing all the questionnaires, 921 questionnaires were found eligible. The findings of the survey showed that a significant proportion of patients who underwent TURP require a long-term postoperative medical therapy. At the same time, in the Russian Federation, there are no standard approaches to medical management of this category of patients.

Urologiia (Moscow, Russia : 1999). 2018 Mar [Epub]

D Yu Pushkar, A N Bernikov, L A Khodyreva, A A Dudareva, S Kh Al'-Shukri, R E Amdii, I A Aboyan, K A Shiranov, V L Medvedev, M E Efremov

A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia.

Pelvic Health Weekly Newsletter